The NIH Department of Health and Human Services’ Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) will award up to $350,000 to projects researching the interaction between tumors and their microenvironment. The research should aim to design new immunotherapy and interventions based on these observed interactions. It is expected that the interventions will lead to improved responses in pre-clinical models and clinical evaluation either in NCI-based early phase networks (ETCTN), or by industry or cancer centers.

Learn more and submit your application here.

Source: Department of Health and Human Services